Furthermore, afamelanotide stimulates BDNF expression in the brain by activating MC4R to mediate neurogenesis and cognitive function in an Alzheimer’s disease animal model [35]. This evidence concerns the gene MC4R and early-onset autosomal dominant Alzheimer disease.